Milad Pharmaceutical offers pharmacokinetic and pharmacodynamic analysis, clinical pharmacology expertise, and drug development strategy.
Development programs are streamlined by improving the efficiency of the Pre-IND phase to Phase II by applying pharmacokinetic, exposure response analysis, model informed drug development analysis and interpretation.
At Milad Pharmaceutical Consulting, the long-standing and trustful relationships we have with our clients, both large and small pharmaceutical companies, are based on good communication, timely analysis, and clear interpretation of results.
Continuous reciprocal communication and leveraged experience between Milad Pharma and clients forms the basis of the success.
Optimal design of drug development programs and pharmaceutical studies ensures the availability of essential data needed to drive timely decision making and regulatory preparedness.
Dose selection, program efficiency, and regulatory
united using model-informed drug development